Candel Therapeutics Inc
CADL
$9.87-3.52%
End of day · as of Oct 6, 2026, 5:00 PM ET
Mkt cap
$592.02M
EV/Sales
3778.3
P/E ratio
N/A
FY2022 Revenue
$125,000
EPS (H1 2026)
$-0.70
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
-15035.20%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
Latest reported CADL revenue for 2022-12-31 was $125.0K. Net income was -$18.8M. CADL currently screens at market cap $592.0M.
Use this CADL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CADL income, balance, and cash tables.
Candel Therapeutics Inc (CADL) is a biotechnology company in the Healthcare sector.
Latest cached Candel Therapeutics Inc (CADL) revenue for Dec 31, 2022 was $125.0K. Net income was -$18.8M. Statements: https://lician.com/financials/cadl
Candel Therapeutics Inc (CADL) market capitalization is $592.0M on the latest cached snapshot.
Candel Therapeutics Inc (CADL) cached previous close $10.23; day range $9.85 – $10.40; volume 971,128. Session quote: https://lician.com/quote/cadl
Candel Therapeutics Inc (CADL) latest cached earnings event is "CADL earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CADL filing is 8-K · Sep 10, 2026. Filings: https://lician.com/sec/cadl